


| Key | % Net Assets |
|---|---|
| 6.5% | |
| 6.1% | |
| 6.0% | |
| 5.2% | |
| 76.2% |
| Name | % Net Assets |
|---|---|
| AstraZeneca PLC | 6.5% |
| GlaxoSmithKline PLC | 6.1% |
| Vodafone Group PLC | 6.0% |
| Imperial Tobacco Group PLC | 5.2% |
| British American Tobacco PLC | 4.7% |
| Royal Dutch Shell PLC | 4.1% |
| Centrica PLC | 4.0% |
| Roche Holding AGCFD | 3.5% |
| BT Group PLC | 3.4% |
| BG Group PLC | 0.0% |
No asset data available.
| Date | 23-Feb-2021 |
|---|---|
| NAV | 189.60p |
| Currency | GBP |
| Change | -1.50p |
| % | -0.77% |
| YTD change | 189.60p |
| YTD % | n/a |
| Fund Inception | 02/02/2009 |
|---|---|
| Fund Manager | n/a |
| TER | 1.75 (28-Feb-2012) |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research